Riskpilot← Back to searchSign inGet full accessH.W INVEST AS
ASActiveOrg 926088033Egdeveien 7, 4307 SandnesPhysiotherapy activities · NACE 8695Est. 20201 employees
Revenue 2025
NOK 1,3M
-18% vs 2024
EBITDA margin
11.1%
-69% vs 2024
Equity ratio
69.3%
Financial strength
Net profit 2025
NOK 125K
-66% vs 2024
| Revenue | NOK 1,3M | -18% |
| EBITDA | NOK 143K | -69% |
| Net profit | NOK 125K | -66% |
| Total assets | NOK 517K | -24% |
| Equity | NOK 358K | -5% |
| Employees | 1 | — |
Legal name
H.W INVEST AS
Org number
926088033
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
2. desember 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Fysioterapi, ultralyddiagnostikk, personlig trener og alt som er naturlig forbundet, handel med og investering i fast eiendom, verdipapirer og andre formuesobjekter, herunder deltagelse i andre selskaper med liknende virksomhet, samt handel innen foto og tilhørende produkter og hva herved står i forbindelse.
Address
Egdeveien 7, 4307 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 837 | 1 042 | 1 248 | 1 581 | 1 293 |
| Staff expenses | −511 | −473 | −700 | −922 | −884 |
| EBITDA | 187 | 395 | 306 | 464 | 143 |
| Depreciation & amort. | −43 | −45 | −52 | −48 | −35 |
| EBIT | 144 | 350 | 253 | 416 | 109 |
| Net financials | −0 | −58 | 13 | 40 | 43 |
| Profit before tax | 144 | 292 | 266 | 456 | 152 |
| Tax | 32 | 77 | 59 | 92 | 27 |
| Net profit | 112 | 214 | 207 | 364 | 125 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 492 | 536 | 610 | 676 | 517 |
| Equity | 142 | 357 | 414 | 378 | 358 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 |
| Short-term debt | 348 | 179 | 196 | 298 | 159 |
| Total debt | 349 | 179 | 196 | 298 | 159 |
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
20212025
Equity ratio
69.3%
This company
38.2%
Market median
+81% vs market
20212025
Return on equity
34.9%
This company
18.4%
Market median
+90% vs market
20212025
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
20212025
Asset turnover
2.50×
This company
1.12×
Market median
+123% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
H.W INVEST AS 
NOR KLINIKKEN STADIONPARKEN ASBoard members of H.W INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Wietfeldt | Chairman | 0 companies |